. . . . "A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adults With DSM-5 Schizophrenia"@en . . . . . . "2022-08-01T00:00:00Z"^^ . "ensayu cl\u00EDnicu"@ast . . . . . "clinical trial"@en . "klinisch onderzoek"@nl . . "ensayo cl\u00EDnico"@es . . . . . . . . "\u062A\u062C\u0631\u0628\u0629 \u0633\u0631\u064A\u0631\u064A\u0629"@ar . . . . . "NCT04738123" . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . "18"^^ . . . "2021-04-06T00:00:00Z"^^ . . "246"^^ . . "A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)"@en . . "A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)"@en . "A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)"@en . . "65"^^ . . . . . . . . .